Donna Dossett
Women's Health · Knoxville, TNNPI 1629190806
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 31.8% of the total. Reporting peaked in 2021 at $916 and has fallen 92.3% since, to $70 in 2025.
Across 92 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$500
- Mayne Pharma Commercial LLC$188
- Daiichi Sankyo Inc.$127
- Takeda Pharmaceuticals U.S.A., Inc.$112
- Aspira Women's Health Inc$104
- Therapeuticsmd, Inc.$77
- plus $464 from 17 others
What the payments were for
- Food & beverage$1,573100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $500 |
| Mayne Pharma Commercial LLC | 10 | $188 |
| Daiichi Sankyo Inc. | 7 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $112 |
| Aspira Women's Health Inc | 2 | $104 |
| Therapeuticsmd, Inc. | 6 | $77 |
| Shield Therapeutics Inc | 1 | $57 |
| Exeltis, USA Inc. | 4 | $51 |
| Channel Medsystems, Inc. | 1 | $48 |
| Pfizer | 2 | $41 |
| Myovant Sciences Inc. | 2 | $38 |
| Avion Pharmaceuticals | 3 | $35 |
| Novo Nordisk | 2 | $31 |
| Merck | 2 | $30 |
| Evofem Biosciences, Inc. | 1 | $22 |
| Teleflex LLC | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Scynexis, Inc. | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Organon | 1 | $13 |
| Neuronetics, Inc. | 1 | $12 |
How this compares
$1,573 in reported general payments places this provider in the 75th percentile of 202 women's health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Medroxyprogesterone Acetate | 18 | $1,141 |
| Metronidazole | 16 | $268 |
Paid to pharmacies, not to this prescriber.
Other women's health in Knoxville
- Anya ZerillaKnoxville$8K
- Catherine KingeryKnoxville$7K
- Brynn WhitworthKnoxville$2K
- Elizabeth ThurmanKnoxville$1K
- Haley WoodFranklin$92K
- Dana DemossNashville$76K
- Royanne MooreNashville$29K
- Laurie TompkinsBrentwood$27K
- Lana HirschNashville$24K
- Yoshie DarnallNashville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.